| Literature DB >> 20708904 |
Ilo E Leppik1, Varun Goel, John Rarick, Donald R Nixdorf, James C Cloyd.
Abstract
A study in dogs demonstrated that the commercially available formulation of IV levetiracetam (LEV) could be given safely IM and was quickly and completely absorbed. In this crossover study, 5 women and 5 men were given IM and IV LEV. This study demonstrates that administration of 5ml (500mg) IM LEV is well tolerated and its bioavailability is equivalent to an IV injection.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20708904 DOI： 10.1016/j.eplepsyres.2010.07.016
Source DB: PubMed Journal: Epilepsy Res ISSN： 0920-1211 Impact factor: 3.045